BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6223578)

  • 1. Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis.
    Cable D; Overturf G; Edralin G
    Antimicrob Agents Chemother; 1983 May; 23(5):688-91. PubMed ID: 6223578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion of moxalactam into the cerebrospinal fluid in children with bacterial meningitis.
    Thirumoorthi MC; Buckley JA; Aravind MK; Kauffman RE; Dajani AS
    J Pediatr; 1981 Dec; 99(6):975-9. PubMed ID: 6458673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefoperazone in full-term and premature neonates.
    Rosenfeld WN; Evans HE; Batheja R; Jhaveri RC; Vohra K; Khan AJ
    Antimicrob Agents Chemother; 1983 Jun; 23(6):866-9. PubMed ID: 6225389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis.
    Modai J; Vittecoq D; Decazes JM; Wolff M; Meulemans A
    Antimicrob Agents Chemother; 1983 Jul; 24(1):126-8. PubMed ID: 6354077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefoperazone in Klebsiella meningitis: a case report.
    Ellis-Pegler RB; Lang SD
    Drugs; 1981; 22 Suppl 1():69-71. PubMed ID: 6456893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential value of cefoperazone in bacterial meningitis: experimental studies.
    Durack DT; Perfect JR
    Drugs; 1981; 22 Suppl 1():60-4. PubMed ID: 6269824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis.
    Scheld WM; Brodeur JP; Sande MA; Alliegro GM
    Antimicrob Agents Chemother; 1982 Oct; 22(4):652-6. PubMed ID: 6217785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology and cerebrospinal fluid penetration of moxalactam in children and dosage recommendations.
    Kaplan SL; Mason EO; Kvernland SJ; Calaway EL; Feigin RD
    Rev Infect Dis; 1982; 4 Suppl():S597-602. PubMed ID: 6218570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations of cefuroxime levels in cerebrospinal fluid of patients with and without meningitis.
    Friedrich H; Haensel-Friedrich G; Langmaak H; Daschner FD
    Chemotherapy; 1980; 26(2):91-7. PubMed ID: 7363711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefoperazone pharmacokinetics in acute childhood meningitis.
    Chartrand SA; Marks MI; Johnston JT; Frederick DF; Scribner RK
    J Pediatr; 1983 Dec; 103(6):991-5. PubMed ID: 6644441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of cefamandole into spinal fluid.
    Steinberg EA; Overturf GD; Baraff LJ; Wilkins J
    Antimicrob Agents Chemother; 1977 Jun; 11(6):933-5. PubMed ID: 879759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transferability of cefpirome to cerebrospinal fluid of rabbits with meningitis caused by Staphylococcus aureus].
    Haruta T; Okura K; Kuroki S; Kobayashi Y
    Jpn J Antibiot; 1991 Jan; 44(1):58-61. PubMed ID: 2041148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of cefoperazone in neurosurgery].
    Kitamura K; Shimizu T; Abe H; Suzuki J; Tanaka R; Nagai H; Yamamoto S; Handa H; Nishimoto A; Matsuoka K
    Jpn J Antibiot; 1986 Jan; 39(1):63-74. PubMed ID: 2939268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration of cefuroxime in cerebrospinal fluid in patients with bacterial meningitis.
    Netland A; Müller C; Andrew E
    Scand J Infect Dis; 1981; 13(4):273-5. PubMed ID: 7313581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation.
    Fong IW; Tomkins KB
    Antimicrob Agents Chemother; 1984 Jul; 26(1):115-6. PubMed ID: 6383206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of initial laboratory investigations in the management of meningitis.
    Nye FJ
    J Infect; 1983 Jul; 7(1):31-8. PubMed ID: 6631027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The penetration of cephalosporins across the blood-brain barrier and its clinical significance].
    Zhang YY; Wu PJ; Zhang Q
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):340-2, 381. PubMed ID: 2582913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of purulent meningitis with a new cephalosporin-Rocephin (Ro 13-9904). Clinical, bacteriological and pharmacological observations in 24 cases.
    Cadoz M; Denis F; Félix H; Diop Mar I
    Chemotherapy; 1981; 27 Suppl 1():57-61. PubMed ID: 7249796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the penetration of antimicrobial agents into the cerebrospinal fluid of experimental animals.
    Sande MA; Sherertz RJ; Zak O; Dacey RG; Bodine JA; Strausbaugh LJ
    Scand J Infect Dis Suppl; 1978; (14):160-3. PubMed ID: 279968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.